HIV i-Base

March/April HTB now online

Featured

Reports from 23rd BHIVA conference on sexual health in the UK, and paediatric and cure-related research from CROI 2017… plus new i-Base appeal…

Pocket ART guide (2017)

Pocket ART is an A7-sized guide to HIV treatment (ART). It is an easy introduction to HIV treatment. Download pocket ART – PDF (300 Kb) Order free printed copies More pocket ART pages ART stands for antiretroviral treatment. HIV drugs are …

January/February HTB now online

14 rapid reports from CROI 2017, plus journal reviews and sexual health in the UK – including drop in HIV diagnoses, PrEP news, and HPV vaccines…

Pocket guides (March 2017)

Featured

NEW: pocket size leaflets based the longer i-Base guides – includes hepatitis C confection and UK guide to PrEP

Fit for purpose: antiretroviral treatment optimisation (Feb 2017)

Some ARVs have shown superior or non-inferior efficacy at reduced doses compared to existing recommended ones. These drugs offer improved durability and tolerability, higher bioavailability, lower pill burden, and the potential for fewer side effects. The ARVs are: dolutegravir (DTG), tenofovir alafenamide …

Early reports from CROI 2017

14 rapid reports from Seattle… new drugs, dolutegravir monotherapy studies stopped, paediatric formulations, PrEP failure case, good news from brain scans… more to follow…

November/December HTB now online

Post-US election issue: reports from Glasgow Congress and Research for Preventions meetings, global treatment, EACS guidelines, UK PrEP updates and more…

September/October HTB now online

PrEP safety, side effects of integrase inhibitors, HIV and children and global access to dolutegravir – reports from four meetings + other news including reduced dose maintenance studies…

July/August HTB now online

News from Durban on HIV prevention including TasP and PrEP, paediatrics, TB and cure research – plus news about PrEP in the UK…

PROUD study closes leaving participants with no access to PrEP

Simon Collins, HIV i-Base On 29 July 2016, the PROUD study website announced that the study will close without being able to continue to provide participants with oral PrEP. [1] The press release blames NHS England for cancelling the previous …

Post navigation